Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

✍ Scribed by J.-L. Chiasson; R. G. Josse; R. Gomis; M. Hanefeld; A. Karasik; M. Laakso; the STOP-NIDDM Trial Research Group

• Publisher: Springer
• Year: 2004
• Tongue: English
• Weight: 147 KB
• Volume: 47
• Category: Article
• ISSN: 0012-186X
• DOI: 10.1007/s00125-004-1409-4